1. Home
  2. CCNE vs GOSS Comparison

CCNE vs GOSS Comparison

Compare CCNE & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNB Financial Corporation

CCNE

CNB Financial Corporation

HOLD

Current Price

$28.04

Market Cap

736.3M

Sector

Finance

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.43

Market Cap

615.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCNE
GOSS
Founded
1865
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
736.3M
615.7M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CCNE
GOSS
Price
$28.04
$0.43
Analyst Decision
Buy
Buy
Analyst Count
2
8
Target Price
$32.00
$5.90
AVG Volume (30 Days)
141.2K
22.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.44%
N/A
EPS Growth
N/A
78.81
EPS
N/A
N/A
Revenue
N/A
$114,701,000.00
Revenue This Year
$23.21
N/A
Revenue Next Year
$7.00
$6.41
P/E Ratio
$11.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.32
$0.33
52 Week High
$30.84
$3.87

Technical Indicators

Market Signals
Indicator
CCNE
GOSS
Relative Strength Index (RSI) 44.15 15.66
Support Level $25.66 N/A
Resistance Level $28.32 $1.31
Average True Range (ATR) 0.92 0.13
MACD -0.17 -0.19
Stochastic Oscillator 6.02 4.38

Price Performance

Historical Comparison
CCNE
GOSS

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. It derives revenue through the operations as a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional customers. The company branch are located in Pennsylvania, Ohio, New York and Virginia.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: